Publication
Title
Hurdles in therapy with regulatory T cells
Author
Abstract
Improper activation of the immune system contributes to a variety of clinical conditions, including autoimmune and allergic diseases as well as solid organ and bone marrow transplantation. One approach to counteract this activation is through adoptive therapy with regulatory T cells (T-regs). Efforts to manufacture these cells have led to good maunfacturing practice-compliant protocols, and T-reg products are entering early clinical trials. Here, we report the stance of the European Union Cooperation in Science and Technology Action BM1305, "Action to Focus and Accelerate Cell-based Tolerance-inducing Therapies-A FACTT," which identifies hurdles hindering T-reg clinical applications in Europe and provides possible solutions.
Language
English
Source (journal)
Science translational medicine. - -
Publication
2015
ISSN
1946-6234
DOI
10.1126/SCITRANSLMED.AAA7721
Volume/pages
7 :304 (2015) , 10 p.
Article Reference
304ps18
ISI
000360943900002
Medium
E-only publicatie
Full text (Publisher's DOI)
Full text (publisher's version - intranet only)
UAntwerpen
Faculty/Department
Research group
Publication type
Subject
Affiliation
Publications with a UAntwerp address
External links
Web of Science
Record
Identifier
Creation 05.10.2015
Last edited 09.10.2023
To cite this reference